|
1) Devic E. Myelite subaiquu compliquee de nevrite optique. Bull Med. 1894; 8: 1033-4
|
|
|
|
|
2) Mandler RN, Davis LE, Jeffery DR, et al. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol. 1993; 34: 162-8
|
|
|
|
|
3) Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999; 53: 1107-14
|
|
|
|
|
|
4) de Seze J, Stojkovic T, Ferriby D, et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci. 2002; 197: 57-61
|
|
|
|
|
|
5) Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M, et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry. 2002; 73: 429-35
|
|
|
|
|
|
6) Misu T, Fujihara K, Nakashima I, et al. Pure optic-spinal form of multiple sclerosis in Japan. Brain. 2002; 125: 2460-8
|
|
|
|
|
|
7) Nakashima I, Fujihara K, Itoyama Y. Oligoclonal IgG bands in Japanese multiple sclerosis patients. J Neuroimmunol. 1999; 101: 205-6
|
|
|
|
|
|
8) Nakamura M, Miyazawa I, Fujihara K, et al. Preferential spinal central gray matter involvement in neuromyelitis optica: an MRI study. J Neurol. In press
|
|
|
|
|
|
9) Cloys DE, Netsky MG. Neuromyelitis Optica. In: Vinken PJ and Bruyn GW editors. Handbook of Clinical Neurology vol. 9. Amsterdam: North-Holland: 1970
|
|
|
|
|
|
10) Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002; 125: 1450-61
|
|
|
|
|
|
11) Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004; 364: 2106-12
|
|
|
|
|
|
12) Wingerchuk DM, Lennon VA, Pittock SJ, et al. Rivised diagnostic criteria for neuromyelitis optica. Neurology. 2006; 66: 1485-9
|
|
|
|
|
|
13) Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005; 202: 473-7
|
|
|
|
|
|
14) Agre OP, Kozono D. Aquaporin water channels: molecular mechanism for human disease. FEBS Lett. 2003; 555: 72-8
|
|
|
|
|
|
15) Nielsen S, Nagelhus EA, Amiry-Moghaddam M, et al. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci. 1997; 17: 171-80
|
|
|
|
|
|
16) Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain. 2007; 130: 1235-43
|
|
|
|
|
|
17) Misu T, Fujihara K, Nakamura M, et al. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med. 2006; 209: 269-75
|
|
|
|
|
18) Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain. 2007; 130: 1224-34
|
|
|
|
|